This site is intended for healthcare professionals only
LoginRegister
Zydus Lifesciences names Nitin D Parekh as President (Special Projects)Zydus Lifesciences names Nitin D Parekh as President (Special Projects)
Biocon expects 50 percent drop in costs for developing complex biosimilars: Top executiveBiocon Biologics Bengaluru facility gets 5 USFDA observations
Chemists Body Seeks Input Tax Credit Refund, Protection Period Amid GST 2.0 RolloutThese 33 Life-Saving Drugs, Including Daratumumab, Alectinib, Obinutuzumab, Now GST-Free, See List
ACB Nabs Government Medical Officer Over Rs 3.70 Lakh BribeVigilance Nabs Drugs Inspector Taking Rs 40,000 Bribe for Pharmacy Licence
Govt Amends UCPMP 2024: CEOs Must Disclose Marketing Expenses, Free Sample Pricing Norms FinalizedGovt Amends UCPMP 2024: CEOs Must Disclose Marketing Expenses, Free Sample Pricing Norms Finalized
Zydus Amplitude receives CE mark for robotic surgical system AndyZydus, Synthon enter licensing, supply agreement for multiple sclerosis drug Ozanimod for US market
CDSCO Panel Seeks More Clinical Data from Regenix Drugs on rDNA-Based Insulin InjectionNovo Nordisk to Discontinue Multiple rDNA Insulin Products in India
Maha: Direct Second-Year B.Pharm Admissions via Diploma Route Surge 60% in 2 Years, Reach 14,010 in 2025-26Maha: Direct Second-Year B.Pharm Admissions via Diploma Route Surge 60% in 2 Years, Reach 14,010 in...
AIIMS Not Obligated to Pay Stipend to Foreign PG Students: Delhi HCPiramal Gets Delhi HC Relief, Decades-Old Spurious Tixylix Cough Syrup Case Quashed
Novartis concludes acquisition of Tourmaline BioNovartis, Argo Biopharma expand strategic alliance with USD 5.2 billion Cardiovascular drugs deal
GE HealthCare Revolution Vibe CT system gets USFDA clearanceGE HealthCare Revolution Vibe CT system gets USFDA clearance
Zydus Lifesciences strikes deal with RK Pharma for novel oncology supportive care injectableNovartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy license
X